Trial
NCT03634800
Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
Multiple Myeloma
Intervention
Nivolumab 240mg
Why stopped
Lack of patient accruals.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-05